MET EXON 14 MUTATION

Clinical trials for MET EXON 14 MUTATION explained in plain language.

Never miss a new study

Get alerted when new MET EXON 14 MUTATION trials appear

Sign up with your email to follow new studies for MET EXON 14 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug combo aims to shrink lung tumors before surgery in targeted trial

Disease control Not yet recruiting

This phase 2 trial tests whether the targeted drug bozitinib, combined with standard chemotherapy, can shrink tumors before surgery in people with stage IIA to IIIC non-small cell lung cancer that has a specific MET gene change. About 34 participants will receive the drug combo f…

Matched conditions: MET EXON 14 MUTATION

Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control

Last updated Jun 26, 2026 13:39 UTC

MET EXON 14 MUTATION

Get alerted when new MET EXON 14 MUTATION trials appear

New drug combo aims to shrink lung tumors before surgery in targeted trial